MD Anderson trial challenges local consolidative therapy paradigm in NSCLC
2 sources·Updated September 12, 2026
Covered by 2 sources
- News-Medical·15h agoMD Anderson trial challenges local consolidative therapy paradigm in NSCLC
Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or progression-free survival in patients with metastatic non-small cell lung cancer (NSCLC), including those with oligometastatic disease, according…
Read at News-Medical → - Medical Xpress·17h agoLocal consolidative therapy does not improve survival after dual immunotherapy in metastatic NSCLC
Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or progression-free survival in patients with metastatic non-small cell lung cancer (NSCLC), including those with oligometastatic disease, according…
Read at Medical Xpress →
